HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Giovambattista De Sarro Selected Research

Gabexate (Foy)

10/2015Targeting mast cells in gastric cancer with special reference to bone metastases.
1/2014Targeting mast cells tryptase in tumor microenvironment: a potential antiangiogenetic strategy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Giovambattista De Sarro Research Topics

Disease

43Seizures (Seizure)
07/2015 - 05/2002
25Epilepsy (Aura)
07/2015 - 08/2003
20Absence Epilepsy (Absence Seizure)
06/2015 - 08/2003
6Stroke (Strokes)
01/2016 - 06/2012
6Schizophrenia (Dementia Praecox)
01/2014 - 01/2006
4Inflammation
01/2016 - 12/2013
4Neoplasms (Cancer)
10/2015 - 01/2013
4Pain (Aches)
02/2014 - 06/2011
4Dementia (Dementias)
02/2014 - 01/2006
3Exanthema (Rash)
04/2014 - 12/2013
3Drug Toxicity (Drug Safety)
01/2014 - 02/2013
3Parkinson Disease (Parkinson's Disease)
01/2014 - 11/2005
2Bone Resorption
10/2015 - 02/2015
2Pervasive Child Development Disorders
07/2015 - 07/2013
2Sarcoma (Soft Tissue Sarcoma)
12/2014 - 02/2014
2Status Epilepticus (Complex Partial Status Epilepticus)
03/2014 - 06/2011
2Psychotic Disorders (Schizoaffective Disorder)
02/2014 - 05/2009
2Mood Disorders (Mood Disorder)
01/2014 - 03/2008
2Colorectal Neoplasms (Colorectal Cancer)
12/2013 - 01/2013
2Fatigue
10/2013 - 11/2010
2Thrombocytopenia (Thrombopenia)
09/2013 - 12/2010
2Multiple Sclerosis
02/2013 - 11/2010
2Rhabdomyolysis
01/2010 - 07/2009
2Agranulocytosis (Granulocytopenia)
01/2006 - 01/2003
1Brain Injuries (Brain Injury)
01/2016
1Cocaine-Related Disorders (Cocaine Addiction)
11/2015
1Neoplasm Metastasis (Metastasis)
10/2015
1Edema
08/2015
1Dyslipidemias (Dyslipidemia)
07/2015
1Brain Diseases (Brain Disorder)
04/2015

Drug/Important Bio-Agent (IBA)

13Anticonvulsants (Antiepileptic Drugs)IBA
12/2014 - 05/2002
10alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
09/2012 - 09/2002
8topiramate (Topamax)FDA LinkGeneric
11/2015 - 05/2004
8Carbamazepine (Tegretol)FDA LinkGeneric
04/2014 - 05/2002
7etiracetam (levetiracetam)FDA LinkGeneric
01/2015 - 07/2007
6Risperidone (Risperdal Consta)FDA LinkGeneric
07/2015 - 01/2003
6lamotrigine (Lamictal)FDA LinkGeneric
10/2013 - 05/2002
4CytokinesIBA
01/2016 - 05/2014
4Tryptases (Tryptase)IBA
10/2015 - 01/2013
4Antipsychotic Agents (Antipsychotics)IBA
06/2015 - 01/2014
4Phenobarbital (Luminal)FDA Link
12/2014 - 05/2002
4AMPA Receptors (AMPA Receptor)IBA
04/2014 - 05/2004
4Carbon MonoxideIBA
01/2014 - 08/2008
4gabapentin (Neurontin)FDA LinkGeneric
10/2013 - 01/2004
4Valproic Acid (Valproate, Semisodium)FDA LinkGeneric
10/2013 - 05/2002
4Pentylenetetrazole (Metrazol)IBA
05/2004 - 09/2002
3quetiapine (Seroquel)FDA Link
06/2015 - 01/2003
3Haloperidol (Haldol)FDA LinkGeneric
06/2015 - 01/2010
3Sirolimus (Rapamycin)FDA Link
11/2014 - 06/2013
3olanzapine (Zyprexa)FDA Link
02/2014 - 01/2003
3Phenytoin (Dilantin)FDA LinkGeneric
10/2013 - 05/2002
3Clozapine (Clozaril)FDA LinkGeneric
09/2008 - 01/2003
32- acetyl- 1- (4'- chlorophenyl)- 6,7- dimethoxy- 1,2,3,4- tetrahydroisoquinolineIBA
08/2008 - 01/2004
3CarbenoxoloneIBA
09/2005 - 01/2004
3N-Methylaspartate (NMDA)IBA
04/2004 - 02/2003
3Diazepam (Valium)FDA LinkGeneric
01/2004 - 05/2002
3Kainic Acid (Kainate)IBA
01/2004 - 09/2002
2Glucose (Dextrose)FDA LinkGeneric
01/2016 - 01/2009
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2015 - 02/2014
2nafamostatIBA
10/2015 - 01/2014
2S- (N- monomethoxytritylaminoethyl)- O- (2- chlorophenyl)phosphorothioateIBA
10/2015 - 01/2013
2Gabexate (Foy)IBA
10/2015 - 01/2014
2imatinib (Gleevec)FDA Link
10/2015 - 02/2014
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
07/2015 - 06/2013
2Antidepressive Agents (Antidepressants)IBA
06/2015 - 07/2011
2duloxetine (Cymbalta)FDA Link
06/2015 - 02/2013
2Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
04/2015 - 12/2013
2ProstaglandinsIBA
04/2015 - 12/2013
22- (2- oxo- 4- propylpyrrolidin- 1- yl)butanamide (brivaracetam)IBA
01/2015 - 01/2015
2Atenolol (Tenormin)FDA LinkGeneric
01/2015 - 05/2002
2aripiprazole (Abilify)FDA Link
01/2015 - 01/2013
2Monoclonal AntibodiesIBA
08/2014 - 12/2013
2Pravastatin (Pravachol)FDA LinkGeneric
08/2014 - 04/2013
2atorvastatin (Lipitor)FDA Link
08/2014 - 04/2013
2Simvastatin (Zocor)FDA LinkGeneric
08/2014 - 04/2013
2perampanelIBA
04/2014 - 03/2014
2Glutamic Acid (Glutamate)FDA Link
03/2014 - 08/2003
2Acetaminophen (Paracetamol)FDA LinkGeneric
02/2014 - 03/2008
2Sodium Channels (Sodium Channel)IBA
10/2013 - 06/2011
2Protein-Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
06/2013 - 12/2012
2zonisamide (Zonegran)FDA LinkGeneric
07/2011 - 07/2009
2Ethosuximide (Zarontin)FDA LinkGeneric
08/2010 - 08/2008
2Neurotransmitter Agents (Neurotransmitter)IBA
06/2006 - 05/2004
2Levodopa (L Dopa)FDA LinkGeneric
02/2006 - 11/2005
2ziprasidone (Geodon)FDA Link
01/2006 - 01/2003
24-Aminopyridine (4 Aminopyridine)IBA
05/2004 - 02/2003
2Kainic Acid Receptors (Kainate Receptor)IBA
01/2004 - 02/2003
22,3- dioxo- 6- nitro- 7- sulfamoylbenzo(f)quinoxaline (NBQX)IBA
01/2004 - 02/2003
1OxygenIBA
01/2016
1masitinibIBA
10/2015
1glargine (insulin glargine)FDA Link
08/2015
1PotassiumIBA
07/2015
1Potassium Channels (Potassium Channel)IBA
07/2015
1Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA
07/2015
1Fluoxetine (Prozac)FDA LinkGeneric
06/2015
1etoricoxibIBA
04/2015
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
04/2015

Therapy/Procedure

4Drug Therapy (Chemotherapy)
12/2013 - 08/2003
3Off-Label Use
10/2014 - 11/2010
2Aftercare (After-Treatment)
04/2015 - 11/2010